Development and evaluation of a community-based buprenorphine treatment intervention
Abstract Background The majority of Americans with opioid use disorder remain out of treatment. Operating in 33 states, Washington DC, and Puerto Rico, harm reduction agencies, which provide sterile syringes and other health services to people who inject drugs, are a key venue to reach out-of-treatm...
Main Authors: | Aaron D. Fox, Nancy L. Sohler, Taeko Frost, Carolina Lopez, Chinazo O. Cunningham |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12954-017-0149-y |
Similar Items
-
Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
by: Margarita Popova, et al.
Published: (2024-12-01) -
Overview of best practices for buprenorphine initiation in the emergency department
by: Terence Hughes, et al.
Published: (2024-02-01) -
Patient’s perspective on early treatment retention in take home buprenorphine maintenance treatment- an explorative study from India
by: P. M, et al.
Published: (2021-04-01) -
Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
by: Hassan Ziaaddini, et al.
Published: (2018-12-01) -
Patient experiences of buprenorphine dispensing from a mobile medical unit
by: Sarah E. Messmer, et al.
Published: (2024-07-01)